THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Christina Washington to Ovarian Neoplasms

Back to Details
This is a "connection" page, showing publications Christina Washington has written about Ovarian Neoplasms.
Christina Washington
Connection Strength
1.864
Ovarian Neoplasms
  1. Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse. Curr Oncol Rep. 2022 Dec; 24(12):1685-1693.
    View in: PubMed
    Score: 0.539
  2. PARP inhibitors in the treatment of ovarian cancer: a review. Curr Opin Obstet Gynecol. 2021 02 01; 33(1):1-6.
    View in: PubMed
    Score: 0.477
  3. Olaparib in the treatment of ovarian cancer. Future Oncol. 2019 Oct; 15(30):3435-3449.
    View in: PubMed
    Score: 0.433
  4. Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research. Curr Opin Obstet Gynecol. 2019 02; 31(1):4-11.
    View in: PubMed
    Score: 0.415
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES